期刊文献+

重视自身免疫性肝病相关自身抗体的规范检测与合理应用 被引量:34

Pay attention to the detection standardization and rational application of autoimmune liver disease relevant autoantibodies
原文传递
导出
摘要 自身免疫性肝病相关自身抗体的检测对自身免疫性肝病(特别是自身免疫性肝炎和原发性胆汁性肝硬化患者)的诊疗具有重要价值。随着临床确诊的自身免疫性肝病患者不断增加,自身免疫性肝病相关自身抗体的检测逐渐受到临床的关注和重视。由于自身免疫性肝病相关自身抗的体检测受到各种因素影响,自身免疫性肝病相关自身抗体检测和临床应用仍存在许多问题。我们应做好自身免疫性肝病相关自身抗体检测的推广普及,重视检测质量管理,不断提高检测质量,加强自身免疫性肝病相关自身抗体的规范检测与合理应用。r手华检验医学杂志,2014,37:8J矗,) The detection of autoimmune liver disease (AILD) relevant autoantibodies is of important value in the diagnosis and treatment of AILD and especially in autoimmune hepatitis and primary biliary cirrhosis. With the increasing of patients clinically diagnosed AILD, the detection of AILD relevant autoantibodies is gradually clinically concerned and appreciated. As the detection of AILD relevant autoantibodies affected by various factors, there are still many problems in the detection and clinical applications of AILD relevant autoantibodies. We should promote the universal clinical application of AILD relevant autoantibodies, emphasis on the quality management and improve the quality of detection constantly, attend to the standard detection and rational application of AILD relevant autoantibodies. ( Chin J Lab Med, 2014,37:81-83)
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2014年第2期81-83,共3页 Chinese Journal of Laboratory Medicine
关键词 肝炎 自身免疫性 肝硬化 胆汁性 自身抗体 质量控制 Hepatitis,autoimmune Liver cirrhosis,biliary Autoantibodies Quality control
  • 相关文献

参考文献14

  • 1Czaja AJ. Diverse manifestations and evolving treatments of autoimmune hepatitis[J].Minerva Gastroenterologica e Dietologica,2005.313-333.
  • 2Kogan J,Safadi R,Ashur Y. Prognosis of symptomatic versus asymptomatic autoimmune hepatitis:a study of 68 patients[J].Journal of Clinical Gastroenterology,2002.75-81.
  • 3Manns MP,Czaja AJ,Gorham JD. Diagnosis and management of autoimmune hepatitis[J].HEPATOLOGY,2010.2193-2213.
  • 4Lindor KD,Gershwin ME,Poupon R. Primary biliary cirrhosis[J].HEPATOLOGY,2009.291-308.
  • 5Hu C J,Zhang FC,Li YZ. Primary biliary cirrhosis:What do autoantibodies tell us[J].World Journal of Gastroenterology,2010.3616-3629.
  • 6Dinani AM,Fischer SE,Mosko J. Patients with autoimmune hepatitis who have antimitochondrial antibodies need long-term follow-up to detect late development of primary biliary cirrhosis[J].Clinical Gastroenterology and Hepatology,2012.682-684.
  • 7Valour F,Durupt S,Khenifer S. Diagnostic value of anti-gp210 antibodies in primary biliary cirrhosis:a case-based review[J].BMJ Case Rep,2013.
  • 8Invemizzi P,Podda M,Battezzati PM. Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis[J].Journal of Hepatology,2001.366-372.
  • 9Cavazzana I,Ceribelli A,Taraborelli M. Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis[J].Journal of Rheumatology,2011.2180-2185.
  • 10Eaton JE,Talwalkar JA,Lazaridis KN. Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management[J].GASTROENTEROLOGY,2013.521-536.

二级参考文献20

  • 1Lazaridis KN, Juran BD, Boe GM, et al. Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis. Hepatology, 2007,46:785-792.
  • 2Kim WR, Lindor KD, Locke GR 3rd, et al. Epidemiology and natural history of primary biliary cirrhosis in a US community. Gastroenterology, 2000,119 : 1631.
  • 3Wong GL, Hui AY, Wong VW, et al. A retrospective study on clinical features and prognostic factors of biopsy-proven primary biliary cirrhosis in Chinese patients. Am J Gastroenterol, 2005, 100:2205-2211.
  • 4Baeres M, Herkel J, Czaja AJ, et al. Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut, 2002,51:259-264.
  • 5Heathcote EJ. Management of primary biliary cirrhosis. The american association for the study of liver diseases practice guidelines. Hepatology,2000,31 : 1005-1013.
  • 6Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol, 1999,31:929-938.
  • 7Irie J, Wu Y, Wicker LS, et al. NOD. c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med, 2006,203 : 1209-1219.
  • 8Oertelt S, Lian ZX, Cheng CM, et al. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor Ⅱ dominant-negative mice. J Immunol, 2006,177 : 1655-1660.
  • 9Wakabayashi K, Lima ZX, Moritoki Y, et al. IL-2 receptor alpha (-/-) mice and the development of primary biliary cirrhosis. Hepatology, 2006,44 : 1240-1249.
  • 10Gershwin ME, Ansari AA, Mackay IR, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev, 2000,174:210-225.

共引文献26

同被引文献235

引证文献34

二级引证文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部